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Background: Genome-wide DNA methylation at a single nucleotide resolution in different primary cells of the
mammalian genome helps to determine the characteristics and functions of tissue-specific hypomethylated regions
(TS-HMRs). We determined genome-wide cytosine methylation maps at 91X and 36X coverage of newborn female
mouse primary dermal fibroblasts and keratinocytes and compared with mRNA-seq gene expression data.
Results: These high coverage methylation maps were used to identify HMRs in both cell types. A total of 2.91% of
the genome are in keratinocyte HMRs, and 2.15% of the genome are in fibroblast HMRs with 1.75% being common.
Half of the TS-HMRs are extensions of common HMRs, and the remaining are unique TS-HMRs. Four levels of CG
methylation are observed: 1) total unmethylation for CG dinucleotides in HMRs in CGIs that are active in all tissues;
2) 10% to 40% methylation for TS-HMRs; 3) 60% methylation for TS-HMRs in cells types where they are not in HMRs;
and 4) 70% methylation for the nonfunctioning part of the genome. SINE elements are depleted inside the TS-HMRs,
while highly enriched in the surrounding regions. Hypomethylation at the last exon shows gene repression, while
demethylation toward the gene body positively correlates with gene expression. The overlapping HMRs have a
more complex relationship with gene expression. The common HMRs and TS-HMRs are each enriched for distinct
Transcription Factor Binding Sites (TFBS). C/EBPβ binds to methylated regions outside of HMRs while CTCF prefers to
bind in HMRs, highlighting these two parts of the genome and their potential interactions.
Conclusions: Keratinocytes and fibroblasts are of epithelial and mesenchymal origin. High-resolution methylation maps
in these two cell types can be used as reference methylomes for analyzing epigenetic mechanisms in several diseases
including cancer.
Please see related article at the following link: http://www.epigeneticsandchromatin.com/content/7/1/34
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Most DNA modification in mammals is the methylation
of cytosine (5mC) in the context of the CG dinucleotide
[1-3]. Non-CG cytosine methylation is observed in
plants, human embryonic stem cells and neuronal cells
[4,5]. CG dinucleotides are underrepresented in the
mammalian genome, a presumed consequence of the
spontaneous deamination of the methylated cytosines to
thymine [6]. A total of 5% of the CG dinucleotides in* Correspondence: vinsonc@mail.nih.gov
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article, unless otherwise stated.the mammalian genome occur in approximately 20,000
clusters termed CG Islands (CGIs), with approximately
half being at the promoters of housekeeping genes [7]. CGI
associated promoters tend to be unmethylated irrespective
of their gene expression, while CG-poor promoters tend to
be methylated and are associated with tissue specific genes
[8]. The present understanding of CG methylation suggests
a diverse role in genome regulation including in the
determination of cell type specificity, cellular differentiation,
suppression of transposable elements, X-chromosome
inactivation, genomic imprinting, DNA-protein interaction
and tumerogenesis [9-17]. Tissue-specific hypomethylated
regions (TS-HMRs) have previously been identified and aretral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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human and mouse cells [15,18,19].
Recently, several single nucleotide resolution maps of
DNA methylation in human [5,20], mouse [19], plants [4]
and honey bee [21] have been possible because of long
read-lengths of the high-throughput Illumina sequencing
platform. These studies revealed several interesting obser-
vations: hypermethylation of CGI shores toward the gene
body was shown to be positively correlated with gene
expression [18,22]; expressed protein-coding genes appear
to have high CG methylation over their gene body
[15,18,23,24]; CG methylation undergoes dynamic changes
at the regulatory regions outside the core promoter during
cellular differentiation [14]. The hypermethylated regions
at the edges of CGIs towards the gene body [18,22] poten-
tially represent methylated exons that are associated with
increased gene expression [15,18,23,24]. CG methylation
increases sequence-specific binding of some transcription
factors, which is essential for gene activation, particularly
in methylated tissue-specific promoters [8,12,15,25].
However, the characteristics and dynamic nature of
tissue-specific DNA methylation changes remain an open
problem. Genome-wide cytosine methylation profiling at
a single nucleotide resolution in different primary cells of
the mammalian genome could help to unravel the charac-
teristics and functional prediction of the TS-HMRs.
Changes in CG methylation occur throughout develop-
ment and pathology. A major event during developmental
differentiation in mammals is the demethylation of regions
of DNA to produce TS-HMRs that may function to activate
expression of nearby tissue-specific genes [14,15,18,25-28].
Single base-pair resolution maps of cytosine methylation
have been published for mammals reinforcing the idea that
CG demethylation occurs in clusters, typically in regions
of high CG density [5,18-20,29]. A recent examination of
42 methylomes from human cells and tissues identified
changes in methylation in 22% of the approximately 20
million CG dinucleotides in the genome [28].
Here, we compared the DNA methylation maps in
newborn female mouse primary dermal fibroblasts and
keratinocytes derived from skin. Understanding the epi-
genomic fingerprint of these two cell types may shed
light on the epithelial to mesenchymal transition (EMT)
observed in cancer [30]. Primary cultures, in comparison
to cell lines have several advantages. Previous studies
have shown that cells with increasing passage number
lead to aberrant epigenetic changes [14]. To help maintain
the proper epigenetic state of these cells, we cultured
primary keratinocytes for three days and dermal fibro-
blasts for eight days without passage. We determined the
high-resolution genome-wide DNA methylation maps
of these two primary cultures using bisulfite-sequencing
and compared these maps to gene expression profiles
obtained using high-throughput RNA-sequencing, toevaluate the role of CG methylation in cell type specificity
determination.
Results
Genome-wide CG methylation in mouse primary
keratinocytes and dermal fibroblasts
Single base pair resolution cytosine methylation maps of
newborn female mouse primary dermal fibroblasts [31]
and epidermal keratinocytes were generated using bisulfite
conversion of genomic DNA and next-generation based
high-throughput Illumina sequencing technology. We
generated 3.75 [31] and 1.38 billion paired-end 102-bp
reads for dermal fibroblasts and keratinocytes, respectively
[see Additional file 1: Table S1a-b]. We aligned 67.8% and
68.1% of the reads uniquely to the reference mouse
genome (mm9) with a false discover rate of 0.007% and
0.004% and generated an average read depth of 91X for
primary dermal fibroblasts [31] and 36X for keratinocytes
[see Additional file 1: Table S1c]. Of the 21,342,779 CGs
in the haploid mouse genome; 13,132,502 CGs are in
unique regions; of these, 98.3% in fibroblasts and 98.2%
in keratinocytes are covered by at least one read [see
Additional file 2: Figure S1a-d, Additional file 1: Table
S1d]. To compare the two methylomes, we used a subset
of the dermal fibroblast data that is comparable to the
keratinocyte methylome coverage [see Additional file 2:
Figure S1e-f, Additional file 1: Table S1c]. The average
cytosine methylation of CG dinucleotides in fibroblasts
and keratinocytes is 65% and 67% respectively [see
Additional file 1: Table S1c]. We observed 5mC in non-
CG methylation of approximately 0.06% in both primary
cells, which represents both CHG and CHH methylation,
and we did not include that in further analysis [see
Additional file 2: Figure S1g-h, Additional file 1: Table
S2a]. Keratinocytes have a higher number of both com-
pletely unmethylated and completely methylated CGs
in comparison to the dermal fibroblasts (Figure 1a-b,
[see Additional file 1: Table S2b]), which may reflect the
more differentiated state of the keratinocytes. Approxi-
mately 2.5 million CGs were sparsely methylated (<10%
methylated), approximately 1.8 million CGs were low-
methylated (10% to 50% methylated), and the remaining
approximately 15.5 million CGs were highly methylated
(>50% methylated) in primary keratinocytes (Figure 1a,
[see Additional file 1: Table S2c-e]), with similar results
for the fibroblasts (Figure 1b, [see Additional file 1: Table
S2c-e]). Adjacent CGs have a similar methylation status
(Pearson’s Correlation = 0.9) but the correlation drops
to 0.3 at approximately 150 bps in both primary cells,
revealing the clustered nature of CG methylation [see
Additional file 2: Figure S2]. Periodicity of correlation
for the methylation of neighboring CG dinucleotides
was also observed previously in the Arabidopsis and















































































































Figure 1 CG Methylation in keratinocytes and fibroblasts. (a-b) Methylation status of all CGs in (a) keratinocytes (Ker) at 36X coverage and in
(b) fibroblasts (Fb) at 91X coverage. (c) Average methylation of CGs in different genomic locations. Each CG is grouped one of the six genomic
locations (Upstream, Promoter, 5’ UTR, Exon, Intron, or 3’ UTR) according to the transcription start site (TSS) and coding sequence (CDS). (d-f)
Comparison of average CGI methylation for Fb versus Ker in different CGI groups: (d) CGIs in Promoter, (e) CGIs in Exons, and (f) the other CGIs.
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from the transcription start site (TSS)), upstream region
(−12 to −2 kbps from TSS), 5’ UTR, 3’ UTR, exons and
introns is similar to previous reports [4,5,19,21,24,33];
these regulatory regions are unmethylated except for the
exons. DNA methylation for keratinocytes is a little higher
(approximately 4 to 5%) than for dermal fibroblasts in
regions away from promoters (Figure 1c). A comparison
of average methylation of different repeat elements in the
two cell types showed higher methylation of long inter-
spersed element (LINE), short interspersed element (SINE)
and long terminal repeat (LTR) elements in keratinocytesthan dermal fibroblasts [see Additional file 2: Figure S3,
Additional file 1: Table S3]. In contrast, repetitive tRNA,
rRNA and regions of low complexity showed identical
methylation patterns in the two cell types [see Additional
file 2: Figure S3]. CG islands (CGIs) that overlap pro-
moters are primarily unmethylated with little difference
between the two cell types (Figure 1d). In contrast,
CGIs that overlap exons are more variable (P < .001,
F-, T-test) (Figure 1d-f). However, gene ontology analysis
of the exons that are differentially methylated in the two
cells does not show any significant enrichment of any GO
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Figure 2 Comparison of hypomethylated regions (HMRs) in fibroblasts and keratinocytes. (a) Venn diagram showing overlapping
fibroblast (91X) and keratinocyte (36X) HMRs. Big color pie charts show genomic localization (five groups) of tissue-specific and common
HMRs. The common HMRs are enriched in the promoter region (red). Small black-white pie charts show the composition of CG methylation.
Low-methylated CGs (10% to 50% methylated, in gray) are enriched in tissue-specific HMRs while unmethylated CGs (<10% methylated, in white)
are enriched in common HMRs. (b) Overlap between keratinocytes (Ker) and fibroblast (Fb) HMRs. The percent of the genome represented for
two tissue-specific (S1) and eight groups of overlapping HMRs (C1-C5) are shown. Pie charts show fraction of HMRs in five genomic regions.
(c) Length comparison between keratinocytes and fibroblasts HMRs. For the tissue-specific HMRs (S1, blue for Fb, and red for Ker), the length
of HMRs in the other cell is 0. (d) Heat map of CG methylation for the tissue-specific and common HMRs along with two published methylomes
for embryonic stem (ES) and neuronal progenitor (NP) cells [19]. The common HMRs are unmethylated (red) in all four methylomes. Fibroblast
and keratinocyte specific differentially methylated regions (S1) are more methylated than the common HMRs (C1). Keratinocyte specific HMRs in
fibroblasts show intermediate methylation compared to neighboring sequences and vice-versa.
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shows that some CG dinucleotides that are methylated
are not conserved [see Additional file 2: Figure S4]. In
contrast, some methylated CGs in exons are more
conserved than the unmethylated CGs [see Additional
file 2: Figure S4].
Comparing hypomethylated regions in keratinocyte and
fibroblast
A two-state Hidden Markov Model (HMM)-based method
was used to detect hypomethylated regions (HMRs) [18] in
both methylomes [see Figure 2, Additional file 2: Figure
S5a-b, Additional file 1: Table S2c-e]. We compared the
fibroblast [31] and keratinocyte HMRs to identify overlap-
ping and tissue-specific HMRs. A Venn diagram of kera-
tinocyte HMRs (2.91% of the genome) and fibroblast
HMRs (2.15% of the genome) shows 34,967 HMRs (0.95%
of the genome) are only in keratinocytes and 12,091 (0.39%
of the genome) are only in fibroblasts (Figure 2a-b).
The remaining HMRs overlap, representing 1.96% of the
genome in keratinocytes compared to 1.76% in fibroblasts
and indicating that the overlapping HMRs are longer in
keratinocytes (Figure 2a-b).
HMRs that overlap between keratinocytes and fibro-
blasts were placed into eight groups (Figure 2b, [see
Additional file 2: Figure S6]). The first group (C1) has
identical boundaries on both sides of the HMRs (0.30%
of genome). The second group (C2) has one common
boundary at one end of the HMR but are longer either
in keratinocytes (0.79% of the genome) or in fibroblasts
(0.73%) [22]. On average, these extended HMRs (C2) are
about 280-bps long and contain 5 CGs. The remaining
three groups (C3 to C5) have more complex overlapping
properties as shown in Figure 2b (keratinocytes (0.87%)
and fibroblasts (0.73%)). The overlapping HMRs include
84% of all CGIs [see Additional file 1: Table S4, Additional
file 2: Figure S6] [7,35,36]. All eight overlapping HMR
groups are mostly enriched in promoters (Figure 2a-b,
[see Additional file 2: Figure S6]) and in contrary,
tissue-specific HMRs are enriched mostly in introns
and intergenic regions (Figure 2a-b, [see Additional file 2:
Figure S6]) [14,19].
Figure 2c presents the length of HMRs in keratino-
cytes and fibroblasts (Figure 2c, [see Additional file 2:
Figure S5a-b]). The Hoxb13 locus is the longest HMR
(38,568 bps) in keratinocytes and fibroblasts with identi-
cal boundaries in both (Figure 2c, [see Additional file 2:
Figure S5c]). For the keratinocyte-specific HMRs, the
average length is 722 bps with 11 CG dinucleotides, and
the longest is approximately 16,000 bps covering the
Mir205 locus (Figure 2c, [see Additional file 2: Figure
S5b,d]) whereas for fibroblast-specific HMRs, the aver-
age length is 862 bps with ten CG dinucleotides, and the
longest is 8,100 bps, which is located in the Skint6 locus(Figure 2c, [see Additional file 2: Figure S5a,e]). HMRs that
overlap in the two methylomes are primarily composed of
CGs that are totally unmethylated, while the tissue-specific
HMRs are primarily composed of low-methylated CGs as
described previously (Figure 2a, [see Additional file 2:
Figure S6, Additional file 1: Table S2c-d]) [19]. This trend is
also observed in the C2 class of HMRs. The overlapping
part of the HMR is composed of unmethylated CGs while
the extended part of the HMR is composed of CGs that are
low methylated (approximately 10 to 20%) [see Additional
file 2: Figure S6].
A heat map of CG methylation in common and TS-
HMRs identified four levels of CG methylation: 1) total
unmethylation, which is for CG dinucleotides in HMRs
in CGIs that are active in all tissues; 2) 10% to 40%
methylation for fibroblast and keratinocyte TS-HMRs; 3)
60% methylation for fibroblast-specific HMRs in kerati-
nocytes, and keratinocyte-specific HMRs in fibroblast;
and 4) 70% methylation for the non-functioning part of the
genome (Figure 2d, [see Additional file 2: Figure S6-7]).
The decrease in methylation of keratinocyte HMRs in
fibroblasts is not the result of cross contamination of
the cultures. This will be shown when we examine the
CpG methylation [see Additional file 1: Table S2b] and
the mRNA-seq data that show tissue specific gene
expression. The sequences corresponding to fibroblast
and keratinocyte-specific HMRs are partially demethy-
lated in mouse embryonic stem (ES) and neuronal pro-
genitor (NP) cells [19] (Figure 2d, [see Additional file 2:
Figure S7-8]), suggesting this to be a general property of
these HMRs. The C1 class of HMRs is also unmethylated
in both ES and NP cells, highlighting their housekeeping
functions (Figure 2d, [see Additional file 2: Figure S7]).
The common and TS-HMRs for both dermal fibroblasts
and keratinocytes show higher CG density than the
surrounding regions [see Additional file 2: Figure S9a-e].
SINE elements are significantly depleted inside the TS-
HMRs, while in the surrounding regions they are highly
enriched in comparison to randomly selected regions of
the genome [see Additional file 2: Figure S10, Additional
file 1: Table S3] [37,38]. In contrast, both LTR and LINE
elements are significantly depleted inside and in the
surrounding regions.
Hypomethylated regions and gene expression
We next determined the mRNA expression of dermal fi-
broblasts and keratinocytes using Illumina high-throughput
RNA-sequencing and compared this to the HMRs.
Biological replicates of the RNA-seq data for both cell
types are reproducible (r >0.99) [see Additional file 2:
Figure S11a-c]. Genes uniquely expressed in dermal
fibroblasts showed enrichment for extracellular matrix
organization, immune response and wound responsive




Figure 3 Comparison of gene expression in fibroblasts and keratinocytes. (a-b) Scatter plot of dermal fibroblasts and keratinocytes RNA-seq
mRNA expression (reads per kilobase per million mapped reads, RPKM) for (a) fibroblasts specific S1 class and (b) keratinocyte specific S1 class of
hypomethylated regions (HMRs) that have TSS within 1-kbp. (c-d) UCSC genome browser screen shots as examples for genes in different group
of HMRs, with mRNA expression, methylation status. (c) Specific HMR (S1) leading to different expression at isoform level, example of Trp63 in
keratinocytes. (d) Fat1 with high CG methylation at the annotated promoter region with expression in both cells, but have HMRs and RNA-seq
signals at approximately 15 Kb upstream.
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Table S5a]. Keratinocyte-specific gene expression showed
enrichment for keratinization and epidermis development
[see Additional file 2: Figure S11d,e; Additional file 1:
Table S5b].
The TS-HMRs within 1 kb of the transcription start
site positively correlate with gene expression in both cell
types with exceptions (Figure 3a, b). Promoters in the C1
class of HMRs with two identical boundaries have variable
expression levels in the two cell types with many (5%)
being more expressed in the fibroblasts [see Additional
file 2: Figure S12a]. Promoters in the C2 class with onecommon boundary and a longer fibroblast HMR (C2S/L)
show an increase in expression (6%) in fibroblasts as seen
for the C1 class [see Additional file 2: Figure S12b]. Many
promoters in the C2 class that is longer in keratinocytes
show increased expression (2%) [see Additional file 2:
Figure S12c]. The more complex overlapping HMRs
(C3-5) show even larger variations in gene expression with
less correlation between HMR length and gene expression,
highlighting the complex relationship between HMRs and
gene expression [see Additional file 2: Figure S12d-h].
The UCSC browser shots highlight different examples of
differential methylation and gene expression (Figure 3c-d,
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isoform level expression of epidermal specific gene P63
(Trp63) in keratinocyte is mediated by the TS-HMR at an
alternative promoter [39]. Similar results are also observed
for fibroblast-specific isoform level expression of Arap1
[see Additional file 2: Figure S13a]. Gene expression for
64 genes with differentially methylated exons within CGIs
[see Additional file 2: Figure S16] shows more highly
expressed genes with methylated CGIs highlighted by
Hoxc13 [see Additional file 2: Figure S13c] [24], while a
few are highly expressed when the CGIs are unmethylated.
These unmethylated CGIs are at the first or second exons
and are essentially extended HMRs like CGI shores
highlighted by Hya12 [see Additional file 2: Figure S13d]
[22,29]. Methylated exons with methylated conserved CGs
are more highly expressed than conserved unmethylated
exons [see Additional file 2: Figure S17-18].
Fat1 shows high expression in both fibroblasts and
keratinocytes with a methylated UCSC genome browser
annotated promoter (Figure 3d). Closer evaluation of this
gene shows that approximately 15 kbp upstream of the
annotated TSS of Fat1, there is a HMR at a CGI, and
RNA-seq data from paired-end 102-bp reads identify tran-
scripts between the annotated promoter and the upstream
HMR, suggesting a misannotation of this promoter; it is
probable that the TSS of this gene is at the upstream
HMR at the CGI, or that it is a new splicing isoform of
Fat1 (Figure 3d, [see Additional file 2: Figure S19]).
Transcription factor binding sites enriched in common
and tissue-specific hypomethylated regions
We evaluated the enrichment of transcription factor bind-
ing sites (TFBS) in the overlapping and TS-HMRs using
two methods. We used support vector machines (SVM)
[40,41] to determine the enriched motifs in keratinocyte
and fibroblast TS-HMRs [see Additional file 2: Figure S20,
S21]. The second method is an enrichment calculation
with respect to the whole genome. We searched for
enriched DNA motifs among the 935 position weight
matrices (PWMs) collected from the TRANSFAC data-
bases [42] in five classes of HMRs: fibroblast-specific
HMRs, keratinocyte-specific HMRs, HMRs common to
keratinocytes and fibroblasts and the tissue-specific exten-
sions of overlapping HMRs in fibroblast and keratinocytes.
Distinct classes of motifs are enriched in each cell type.
P63, P53 and TFAP2 are enriched in keratinocytes specific
HMRs [see Additional file 2: Figure S20a] and are sig-
nificantly expressed in this cell type (Figure 3c, [see
Additional file 2: Figure S21a]). In dermal fibroblasts,
ELK1, E2F1, CREB, CREBP, ETS motifs are prominently
enriched [see Additional file 2: Figure S20a], and the
mRNA for the transcription factors (ELK1, E2F1, CREB3l1
and CREB3l2) that bind these motifs are significantly
expressed [see Additional file 2: Figure S21a]. Examiningthe tissue-specific extensions of common HMRs (C2-C5),
shows that the motifs enriched are similar to those in the
tissue-specific HMRs [see Additional file 2: Figure S20b-c,
S21b-g]. The common HMRs are enriched for CNOT3,
ZF5, E2F1, AP2 and ETF [see Additional file 2: Figure
S20d, S21b-g].
C/EBPβ binds in methylated regions
We examined the localization of two TFs using ChIP-seq,
one that preferably binds methylated motifs (C/EBPβ)
outside of HMRs and a second that preferably binds
unmethylated motifs (CTCF) in HMRs. C/EBPβ is a
B-ZIP transcription factor that preferentially binds
methylated motifs [8,31]. C/EBPβ ChIP-seq data identified
7,317 and 7,679 peaks in dermal fibroblasts and keratino-
cytes with approximately 2/3 overlapping (Figure 4a, b).
The overlapping and tissue-specific C/EBPβ peaks are dis-
tributed in the genome similarly with approximately 2/3
in methylated regions, approximately 1/6 in unmethylated
regions and approximately 1/6 in regions of differential
methylation (Figure 4a). Among the commonly bound C/
EBPβ peaks, 423 C/EBPβ bound sites are in unmethylated
promoter regions (Figure 4a, [see Additional file 1: Table
S6-7]). The motifs in the commonly bound peaks are
mainly the consensus C/EBP sites that contain a central
CG dinucleotide or its deaminated TG/CA dinucleotide,
which is more abundant [see Additional file 2: Figure
S22a]. Fibroblast-specific C/EBPβ ChIP-seq peaks shows
enrichment for AP1 and SP1 motifs in addition to the
consensus CEBP sites, while for keratinocytes, we only
observe enrichment for the C/EBP motif [see Additional
file 2: Figure S22a]. Examining tissue-specific C/EBPβ
peaks that are differentially methylated does not identify a
simple relationship between methylation and binding [see
Additional file 1: Table S6-7], even though methylation
enhances C/EBPβ binding in vitro [8,31]. Figure 5 presents
an example of C/EBPβ binding to a methylated canonical
C/EBP motif (TTGC|GCAA). Several global C/EBP local-
ization data sets have been published [43,44], but none
has highlighted C/EBPβ localization in the methylated
regions of the genome.
CTCF binds in hypomethylated regions
CTCF is a zinc finger protein initially known for its insulat-
ing properties at the beta globin locus [45-47]. More recent
work has identified CTCF primarily at unmethylated re-
gions of the DNA [19,48]. CTCF ChIP-seq data identified
approximately 12,000 peaks in fibroblasts and approxi-
mately 16,000 peaks in keratinocytes with approximately
10,000 being common (Figure 4c, d). Among the common
CTCF peaks between these two cell types, approximately
96% of CTCF peaks are in HMRs, which are primarily
promoters (87%) in CGIs (83%) [see Additional file 1:




Figure 4 C/EBPβ and CTCF chromatin immunoprecipitation (ChIP)-seq peaks in fibroblasts and keratinocytes. (a) Venn diagram showing
C/EBPβ ChIP-seq peaks in fibroblasts and keratinocytes. The common peaks are in methylated regions (61%) and tissue-specific C/EBPβ peaks are
even more enriched in methylated regions (approximately 70%). (b) Scatter plot of number of reads in C/EBPβ bound ChIP peaks in dermal fibroblasts
and keratinocytes. (c) Venn diagram showing that the majority of CTCF ChIP-seq peaks overlap between fibroblast and keratinocyte. 96% of the
common peaks are in unmethylated regions and enriched in the promoters (87%). The tissue-specific CTCF peaks are also primarily in unmethylated
regions enriched for promoters. The 3% of common CTCF peaks in methylated regions tend to occur in exons (64%). (d) Scatter plot of number of
reads in CTCF bound ChIP peaks in dermal fibroblasts and keratinocytes.
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ferentially methylated are enriched in exons (64%) [49].
The tissue-specific CTCF peaks that are in methylated
regions (12% in fibroblasts and 21% in keratinocytes)
also tend to occur in exons [see Additional file 1: Table
S6-S7]. The motifs in the commonly bound peaks are
mainly the consensus CTCF, KLF, SP1 and SP2 sites, as
previously reported [46,50], which are GC rich and
contain CG dinucleotide [see Additional file 2: Figure
S22b]. Fibroblast-specific CTCF ChIP-seq peaks show
enrichment for ZEB1 motif in addition to the consensus
CTCF sites, while for keratinocytes, we observe that theenriched motifs are similar to the common bound peaks
[see Additional file 2: Figure S22b]. An examination of the
tissue-specific peaks that are differentially methylated
identifies no simple relationship, even though it has been
reported that CG methylation inhibits CTCF binding
[19,48].
Discussion
We used bisulfite-based MethyC-seq technology to
determine the genome-wide single nucleotide cytosine
methylation maps for newborn female mouse primary
dermal fibroblasts [31] and keratinocytes and identified
Figure 5 C/EBPβ binding to the methylated canonical C/EBP motifs (TTGCGCAA). UCSC genome browser screen shots as example for
C/EBPβ binding to the methylated canonical C/EBP motif of TTGCGCAA in both fibroblasts and keratinocytes.
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Out of 1.4 million completely unmethylated CGs in the
primary keratinocytes, 72% are in HMRs and represent
2.9% of the genome, indicating the clustered nature of
unmethylated CG dinucleotides in the mouse genome.
This is reflected in the correlation of CG methylation
among the first and second neighboring CGs [see
Additional file 2: Figure S2]. Methylated cytosines are
prone to deamination and often are less conserved in the
genome [6,51,52]; however, methylated CGs in exons
showed more conservation than the unmethylated CGs
in exons highlighting their potential importance [24].
Comparing HMRs from the two cell types identified
overlapping HMRs and tissue-specific HMRs. Over-
lapping HMRs tend to be longer and enriched in pro-
moters containing CGIs, compared to the TS-HMRs,
which tend to be shorter and not in promoters. Over-
lapping HMRs were also unmethylated in two add-
itional (ES and NP) mouse methylomes, suggesting
housekeeping functions. Both the overlapping and TS-
HMRs are more CG rich and evolutionarily conserved
than the surrounding regions. Comparing the two
methylomes allowed the identification of four classes of
CG dinucleotides. These methylation frequencies are a
trait of a population of cells, not an individual cell, and the
mechanisms that can produce CG dinucleotides with four
distinct methylation profiles highlight the dynamic nature
of CG methylation.Different TFBSs are enriched in the common HMRs,
the keratinocyte TS-HMRs, and the fibroblast TS-HMRs.
The TFs that bind the TFBSs enriched in the common
HMRs are expressed in both cell types, while the TFs that
bind TFBS enriched in the fibroblast TS-HMRs are only
expressed in the fibroblast, as is also true for keratino-
cytes. The TFBSs that are enriched in the unique TS-
HMRs are also enriched in the tissue-specific portion of
the overlapping HMRs. Among the top keratinocyte-
specific TFBSs, P53 and P63 binding sites do not necessar-
ily contain a CG in their consensus binding site and
should not be regulated by methylation. However, methy-
lation of the AP2α motif is reported to inhibit DNA
protein binding [53,54]. The top five transcription factors
enriched in common HMRs contain CG in their binding
sites and methylation is known to inhibit DNA binding of
several TFs [55]. Methylation inhibits binding to E2F
TFBS for all family members of E2F [56]. Methylated AP2
and Zf5 sites have also been reported to inhibit DNA pro-
tein binding by AP2 and Zf5 TFs [53,57]. The mechanism
that connects TFs with HMRs is an important question to
examine going forward.
Comparing the HMRs with mRNA-seq data for both
cell types identified several general patterns. We identified
examples of TS-HMRs at promoters where unmethylation
positively correlates with gene expression. Classic exam-
ples in keratinocytes are P63, keratin1, and keratin5 and
in fibroblasts are ARAP1, and NNMT (Figure 3c, [see
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examples of HMRs being extended toward the body of the
gene and demethylation towards the gene body positively
correlating with gene expression. This is analogous to
what was observed for CGI shores [22]. Another pattern
is methylation at the last exon that positively correlates
with gene expression [see Additional file 2: Figure S13c-d]
[15,24,33]. HMRs are not always associated with gene
expression. For example, the longest HMR is identical in
both cell types and overlaps with the Hoxb13 gene [see
Additional file 2: Figure S5c]. This gene is not expressed
in either cell type, suggesting some other mechanism, for
example activating histone marks is required for the
activation of this gene.
ChIP-seq for C/EBPβ and CTCF highlight the two parts
of the genome, the HMRs representing 2 to 3% of the
genome and the remaining methylated genome. A total of
96% of CTCF peaks are in HMRs, while 70% of the C/EBPβ
peaks are in the methylated regions. CTCF is present in
several promoters with HMRs, while the C/EBPβ binding to
the methylated sites is mostly enriched in introns and inter-
genic regions. Evaluating the genome-wide binding of these
two transcription factors clearly shows that there are two
parts to the genome and mechanisms of how these two
parts communicate needs to be explored in more detail.
Conclusions
Keratinocytes and fibroblasts are of epithelial and mesen-
chymal origins, two of the three primary germ layers. Pri-
mary dermal fibroblasts cultures in the presence of serum
showed a gene-expression pattern very similar to that of
oncogene expressing cancer cells. In contrast, epidermal
keratinocytes express tumor suppressor genes. However, in
dermal fibroblasts, we showed a different mechanism of
gene regulation at these genes. CGIs at these two cell types
are largely invariable; however, demethylation at the CG-
shores or HMR-shores toward the gene body is shown to
be correlated with the expression of these genes. Addition-
ally, many non-CGI HMRs at the alternative promoters are
shown to regulate the expression of tumor suppressor or
oncogenes suggesting an epigenetic regulation of gene
expression beyond CGIs. TS-HMRs have less methylation
than surrounding DNA in all four methylomes examined,
suggesting a dynamic methylation-demethylation process
at these regulatory regions [58]. These high-resolution
methylation maps and the RNA-seq data in these two
primary cell types can be used as reference methylomes
and transcriptomes for evaluating both pathological
methylomes and differentiation of stem cell [59].
Methods
Mouse primary keratinocytes and dermal fibroblasts
NIH research guidelines and IACUC-approved animal
study protocols were followed in this study. Keratinocytesand dermal fibroblasts were cultured from wild-type new-
born mice according to the protocol described previously
(Rishi et al. [8]). Primary keratinocytes were seeded at a
density of one mouse epidermis per 10-cm dish or equiva-
lent in calcium- and magnesium-free SMEM (GIBCO
Laboratories, Grand Island, NY, USA), supplemented with
8% Chelex (Bio-Rad, Richmond, CA, USA)-treated FBS
(Atlanta Biologicals, Inc) and 0.2 mM calcium (CaCl2).
Dermal fibroblasts were also seeded at a density of one
mouse dermis per 10-cm dish or equivalent in DMEM/
F12: GlutaMAX medium (Invitrogen, USA) with 10% FBS.
RNA-sequencing in keratinocytes
Total RNA was isolated from the mouse primary kerati-
nocytes and dermal fibroblasts. Purified RNA was used
for generating the mRNA-seq library using the Illumina
mRNA-seq kit as described in the manufacturer's proto-
col. Data analysis was performed using Partek Genomic
suite with the default parameters. Transcript abundances
were reported in RPKM (reads per kilobase per million
mapped reads) with arbitrary units.
Determination of whole genome DNA methylation in
keratinocytes
Genomic DNA was isolated from primary keratinocytes
that had been cultured for 3 days, and bisulfite sequencing
was used according to the protocol described previously
[31]. Approximately 10 μg of genomic DNA was sonicated
to approximately 300 bp using the Covaris S2 System.
Sonicated DNA was purified using Qiagen DNeasy MinE-
lute columns (Qiagen Inc., USA). Each sequencing library
was constructed using the Illumina paired-end DNA
sample preparation kit (Illumina Inc., USA) according to
the manufacturer's instructions, with the following modifi-
cations: Illumina methylated adapters were used in place
of the standard genomic DNA adapters. Ligation products
were purified with AMPure XP beads (Beckman Coulter,
USA). 4 × 500 ng of DNA were bisulfite-treated using the
EpiTect Bisulfite Kit (Qiagen Inc., USA) following the
manufacturer's guidelines, followed by PCR amplification
using the Phusion Taq using the following PCR condi-
tions: 2 min at 95°C, 4 cycles of 15 sec at 98°C, 30 sec at
60°C, 4 min at 72°C, and 10 min at 72°C. Libraries were
sequenced using the Illumina HiSeq 2000 (Illumina Inc.,
USA) up to 101 cycles. Mapping the bisulfite-treated reads
was done with methods described previously [31] with
tools from Novoalign and Novomethyl (Novocraft Tech-
nologies, http://www.novocraft.com/) packages. Hypo-
methylated regions (HMRs) were identified with a hidden
Markov model (HMM) as described previously [18]. The
false positive rate of the maps of bisulfite sequencing
reads was calculated two ways: one, considering the
non-CG cytosine methylation and second, considering
the chromosome Y cytosine methylation because we used
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Although, non-CG methylation is observed in the ES
cells and chromosome Y has some homologies to the
chromosome X, two things that might cause a false
estimation of the calculation, the false positive rate of
these two methylomes is considerably low.
Chromatin immunoprecipitation sequencing of C/EBPβ
and CTCF
C/EBPβ and CTCF chromatin immunoprecipitation
(ChIP) sequencing from primary dermal fibroblasts and
keratinocytes were done as described previously [31].
Briefly, primary cultured dermal fibroblasts and keratino-
cytes were chemically cross-linked for 10 min by adding
0.6% formaldehyde (Sigma, USA) directly to the medium.
The cross-linking reaction was stopped by adding 125 mM
glycine, and dishes were swirled for 5 min at room
temperature. Cells were washed twice with ice-cold
PBS and harvested in ice-cold PBS containing protease
inhibitor (Roche, USA). A total of 107 cells were pel-
leted by centrifugation at 4°C for 5 min at 300 g. Four
times, 300 μl of sonicated chromatin preparation was incu-
bated overnight with C/EBPβ (sc-150; Santa Cruz) or
CTCF antibody (sc-15914; Santa Cruz). Immunocomplexes
were captured using protein G agarose beads (Invitrogen
Inc., USA) and washed twice with the buffer containing
2 mM EDTA, 100 mM Tris-Cl, pH 8.0, and 0.18% Sarko-
syl, and four times with the IP buffer (100 mM Tris-Cl,
pH 8.5, 500 mM LiCl, 1% NP40, 1% deoxycholic acid).
After being incubated with RNaseA and Proteinase K,
DNA was eluted using a QIAquick PCR Purification Kit
(Qiagen, Germany). Purified DNA were used to prepare
the library for Illumina high-throughput sequencing using
Illumina Single End ChIP-seq Sample Preparation Kit, as
described in the manufacturer's protocol. Libraries were se-
quenced to generate 35-bp single-end reads using Illumina
GAII sequencing machines. We used the Model-Based
Analysis of ChIP-seq (MACS) algorithm [60] with default
parameters for detecting the ChIP-seq peaks of C/EBPβ
and CTCF.
Calculation of motif enrichment in tissue-specific and
common hypomethylated regions
To determine the enriched motifs in tissue-specific and
common HMRs, we calculated an enrichment score for
each motif. To avoid the bias of sampling from the
mouse genome, we searched each motif on the whole
genome. In each chromosome, motifs were searched
using MAST in MEME suite [61] with the position
weight matrices (PWMs). The PWMs we used were col-
lected from the TRANSFAC databases [42] in which 935
PWMS are provided, and MAST was run with default
parameters. For each motif M with the length L we
denote M(xstart:xend) to record the positions where themotif starts and ends: x1:x1 + L-1, x2: x2 + L-1 … xN:
xN + L-1, N being the total number of motifs in genome.
For each position xi: xi + L-1, if it overlapped with the
examined regions (HMRs), xi = 1, otherwise xi = 0. For
whole HMRs, the observed (OCCobs) and expected
(OCCexp) occurrences of the motif are calculated as: O
CCobs ¼
XN
i¼1xi and OCCexp ¼ N 
Lr
Lg
, where N is the
total number of motif in the whole genome, Lr is the
total length of base pairs in the examined regions
(HMRs), and Lg is the total length of base pairs for the
whole mouse genome. The enrichment score (E) for
motif M is calculated as following: E ¼ OCCobsOCCexp , where
OCCobs is the observed occurrences, and OCCexp is the
expected occurrence of motif M in examined regions
(tissue-specific or common HMRs).
UCSC annotations of exon, intron, 5'UTRs, 3'UTRs, and
promoters (0 to −2 kbps) were used for the analysis. UCSC
genome browser screen shots were generated using custom
tracks of the UCSC web site (https://genome.ucsc.edu/).
Data submission
Keratinocyte methylome data have been submitted to
the GEO database with accession number (GSE44918).
Two biological replicates of keratinocytes mRNA-seq data,
C/EBPβ and CTCF ChIP-seq data will be submitted to the
GEO database (GSE44918). Fibroblasts methylome, C/
EBPβ ChIP-seq and mRNA-seq data have been obtained
from the GEO accession number (GSE44942) [31]. The
CTCF ChIP-seq data and the second biological replicate
RNA-seq data of dermal fibroblasts will be submitted
to the GEO database (GSE44942). The data can also be
obtained from the authors upon request.Additional files
Additional file 1: Table S1. Sequencing reads and aligned reads.
Table S2. Statistics of methylated cytosines. Table S3. Repeats in UCSC
repeat masker. Table S4. HMRs overlap with CpG Islands. Table S5.
Fb and Ker mRNA GO analysis. Table S6. Total number of unmethylated
and methylated tissue specific and common peaks of C/EBPβ and CTCF.
Table S7. Distribution of unmethylated and methylated tissue specific
and common peaks of C/EBPβ and CTCF based on CGI and non-CGI.
Additional file 2: Figure S1. Methylation of CGs and coverage in
fibroblasts and keratinocytes. Figure S2. Adjacent CGs have a similar
methylation status. Figure S3. Comparison of CG methylation in different
repetitive elements in fibroblasts and keratinocytes. Figure S4. Methylated
CGs at exons are more conserved than the unmethylated CGs. Figure S5.
HMRs in fibroblasts and keratinocytes. Figure S6. Overlap with CGIs and
composition of different methylated CGs in tissues-specific HMRs (S1) and
common HMRs (C1-C5). Figure S7. Heatmap of CG methylation for
the different groups of keratinocyte HMRs in different cells. Figure S8.
Comparison of HMRs in fibroblasts, keratinocytes, embryonic stem cells and
neuronal progenitor cells. Figure S9. HMRs are the conserved regions with
high GC content as well as CpG density. Figure S10. SINE elements are
depleted inside the HMRs, but enriched in the surrounding regions;
however, both LTR and LINE elements are depleted in both inside and at
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genome browser screen shots as examples for tissue specific genes
expression with TS-HMRs near the TSS of Krt1, Krt5 and NNMT1. Figure S15.
UCSC genome browser screen shots as examples for extended HMRs
leading to enhanced gene expression of Emilin1, Trp53il1 and Wnt3.
Figure S16. Correlation between the methylation difference and gene
expression changes in fibroblasts and keratinocytes. Figure S17. Exons with
methylated conserved CGs are highly expressed. Figure S18. Exons with
methylated conserved CGs are highly expressed. Figure S19. RNA-seq
signal at the Fat1 locus. Figure S20. Transcription factor binding sites (TFBS)
in HMRs. Figure S21. Comparison of enriched TFBS motifs in the fibroblasts
and keratinocyte HMRs. Figure S22. Binding motifs in C/EBPβ and CTCF
ChIP-seq peaks.
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